Brief: Vaccinex Reports First Quarter 2023 Financial Results And Provides Corporate Update
15/05/2023 22:46
Vaccinex Inc VCNX.O :
* VACCINEX REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS AND
PROVIDES CORPORATE UPDATE
* VACCINEX INC - QTRLY LOSS PER SHARE $0.10
Source text for Eikon: ID:nGNX2274Wc
Further company coverage: VCNX.O
Recent news on Vaccinex
See all newsBrief: Vaccinex Reports Third Quarter 2024 Financial Results And Provides Corporate Update
Brief: Vaccinex Says On Oct 7, Got Letter From The Nasdaq Listing Staff Stating That Co Had Not Regained Compliance With The Equity Standard
Brief: VaccinexExercise Of Warrants For $6.2 Million In Gross Proceeds
Brief: Vaccinex Provides Update On New Findings For Signal-Ad Phase 1B/2 Trial Of Pepinemab In Alzheimer’S Disease
Brief: Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepinemab Treatment for Alzheimer’s Disease